Study shows how prostate tumors rewire metabolism to resist therapy - News-Medical
New research reveals how prostate tumors adapt to evade hormone therapy, affecting treatment outcomes for patients.
12 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 12 separate news trends connected to Prostate Cancer, spanning June 21, 2026 through August 22, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 82 article observations and 78 source signals, led by Health, Entertainment coverage. Use it to compare how individual events emerged, spread and changed over time.
New research reveals how prostate tumors adapt to evade hormone therapy, affecting treatment outcomes for patients.
A new study indicates that MRI scans may eliminate the necessity for invasive biopsies in diagnosing prostate cancer for many patients.
Men over 50 in the UK will no longer be automatically entitled to prostate cancer blood tests.
Recent research links the consumption of ultra-processed foods commonly found in American diets to an elevated risk of developing prostate cancer.
Researchers are using CRISPR gene-editing technology to re-sensitize prostate tumors to immunotherapy treatments.
Researchers have developed a fully human antibody drug capable of halting the growth and metastasis of aggressive prostate cancer in lab models.
Medical professionals and health outlets highlight the critical role of early detection and robotic surgery in treating rising prostate cancer cases.
A study from Imperial College Healthcare NHS Trust indicates focal therapy for prostate cancer matches surgery and radiotherapy in efficacy.
A new blood test called Stockholm3 is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
A new multicomponent blood test is demonstrating higher detection rates for clinically significant prostate cancer compared to traditional PSA testing.
The NHS is expanding access to high-powered radiotherapy for thousands of men with prostate cancer to reduce treatment times.
Jeremy Clarkson is urging the public to seek medical screenings after revealing his battle with aggressive prostate cancer.